Stay updated on Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 removed on the page. This appears to be a version update with no impact on the trial details visible on the page.SummaryDifference0.0%

- Check19 days agoChange DetectedThe visible site-wide notice about government funding and data currency was removed from the page. This banner is ancillary to the study details and does not affect the trial information presented.SummaryDifference0.3%

- Check33 days agoChange DetectedThe new screenshot shows minor UI adjustments (layout spacing) on the Study Details page with no changes to study content such as inclusion criteria, primary/secondary outcomes, or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange Detected- Added a government operating-status notice and guidance, including links to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check69 days agoChange DetectedPage updated to v3.1.0; removed the Ovarian cancer resource and old v3.0.2 reference.SummaryDifference0.4%

- Check83 days agoChange DetectedThe page updates from v3.0.1 to v3.0.2, and the 'Back to Top' link is removed; no substantive content changes (e.g., pricing or availability) were introduced.SummaryDifference0.2%

Stay in the know with updates to Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial page.